Products

EmbracePlus
Empatica S.R.L.
Drug Discovery & Research
EmbracePlus by Empatica is an FDA-cleared medical-grade wearable device and platform for continuous physiological monitoring, digital biomarker development, and remote data collection in clinical trials and academic research.
Empatica Care
Empatica S.R.L.
Clinical Decision Support & Reference
Empatica Care is part of the Empatica Health Monitoring Platform, utilizing medical-grade wearables to collect continuous physiological data for remote patient monitoring and clinical research, accessible via a mobile app and web portal.

See all 2 products →

About Empatica S.R.L.

Empatica S.R.L. is a leading healthcare AI company specializing in the development of medical wearable devices and a comprehensive health monitoring platform. Their technology leverages AI and sensor-based systems to continuously and remotely monitor various physiological and behavioral biomarkers, including heart rate, electrodermal activity, skin temperature, and movement. This data is used to provide real-time human insights for health monitoring, forecasting, treatment, and research.

For physicians, Empatica’s platform offers FDA-cleared and CE-MDR certified tools designed for remote patient monitoring and decentralized clinical trials across numerous therapeutic areas. Their products, such as EmbracePlus and EmbraceMini, are utilized in studies examining conditions like epilepsy, Parkinson’s disease, sleep disorders, mental health, and cardiovascular issues. The platform facilitates the collection of medical-grade data from patients in their homes, supporting the development of digital biomarkers and providing valuable insights for treatment research and clinical care.

Empatica’s commitment to advancing digital health is evident in its pioneering work, including the development of the first FDA-cleared digital biomarker in neurology. They also offer an end-to-end solution for clinical trials, covering aspects from patient enrollment to data collection and management. The company has also expanded its offerings to include Parkinson’s monitoring through the acquisition of PKG Health, integrating validated algorithms for movement disorder monitoring.

Focus Areas

AI-enabled wearables digital biomarkers remote patient monitoring decentralized clinical trials epilepsy monitoring Parkinson's monitoring sleep and activity tracking neurological conditions mental health movement disorders

Business Intelligence

TechnologyEmpatica Health Monitoring Platform (integrates wearable data, cloud-based infrastructure, AI-based algorithms, biosensors for continuous physiological monitoring and analysis)

What Physicians Need to Know

Digital Biomarker Development
Empatica specializes in pioneering digital biomarker development, offering a vast selection of clinically validated and research-grade digital biomarkers. They develop accurate physiological and behavioral digital biomarkers for healthcare diagnostics and clinical trials, including customized biomarker development tailored to specific research or clinical objectives.
Continuous Health Monitoring & Remote Patient Monitoring
Empatica is a leader in continuous remote health monitoring, utilizing medical wearables and connected technology to transform real-world health data into actionable insights. Their FDA-cleared products support clinical trials, research, and daily care across various neurological and health conditions. The Empatica Health Monitoring Platform enables continuous, remote monitoring of patient physiology in home and healthcare environments.
AI & Wearable Sensors
Empatica designs and develops AI-enabled wearables, software, and digital biomarkers to advance health monitoring, forecasting, treatment, and research. Their wearable devices, such as EmbracePlus and EmbraceMini, measure and track physiological signals like heart rate, heart rate variability, electrodermal activity, motion, acceleration, and skin temperature. These devices are FDA-cleared and CE MDR certified.
Epilepsy Monitoring
Empatica offers EpiMonitor, an FDA-cleared seizure detection and epilepsy monitoring system. It consists of the EmbracePlus watch and a companion smartphone app, continuously monitoring health data, detecting possible generalized tonic-clonic seizures, and alerting caregivers.
Parkinson's Monitoring & Movement Disorders
Empatica's Parkinson's Monitoring combines clinically validated motor assessments with their FDA-cleared and CE MDR certified wearable technology. This platform continuously tracks motor symptoms and therapy response, supporting informed and personalized treatment decisions. It provides validated measures of bradykinesia, dyskinesia, tremor, sleep, and medication compliance.
Sleep Monitoring
Empatica provides clinical-grade wearables and a platform to support sleep monitoring in clinical research, offering continuous actigraphy-based sleep monitoring and longitudinal data collection in real-world settings. Their EmbraceMini device is FDA-cleared for sleep monitoring, enabling high-quality sleep and circadian rhythm assessments.
Stress Monitoring
Empatica's wearables measure electrodermal activity (EDA), which can be used to assess signals from the nervous system, including sympathetic and parasympathetic activity, relevant for stress monitoring.
Clinical Trials & Decentralized Clinical Trials
The Empatica Health Monitoring Platform is an end-to-end remote monitoring solution for clinical trials, covering remote patient enrollment, device provisioning, continuous automated data collection, and clinical data management. It is FDA-cleared and developed to provide medical-grade data collected continuously from participants' homes.
Physician Tip

Physicians can leverage Empatica's FDA-cleared and CE MDR certified wearable technology for continuous, objective monitoring of neurological conditions like epilepsy and Parkinson's disease, enabling more personalized and data-driven treatment decisions. The platform provides validated digital biomarkers for motor symptoms, sleep, and activity, offering insights beyond traditional in-clinic assessments. For epilepsy, EpiMonitor offers automatic seizure detection and alerts for caregivers, enhancing patient safety and management. For Parkinson's, the platform provides comprehensive insights into bradykinesia, dyskinesia, tremor, and medication compliance. The ability to collect real-world, longitudinal data can significantly improve understanding of disease progression and treatment effectiveness.

The Empatica Health Monitoring Platform is designed for integration into existing clinical trial workflows and offers a Cloud API for seamless data integration with other systems. It supports eCOA and ePRO data collection strategies and is compliant with 21 CFR Part 11, HIPAA, and GDPR for secure data management.

Products by Empatica S.R.L.

2 products in the directory

EmbracePlus
Empatica S.R.L.
Drug Discovery & Research
EmbracePlus by Empatica is an FDA-cleared medical-grade wearable device and platform for continuous physiological monitoring, digital biomarker development, and remote data collection in clinical trials and academic research.
Empatica Care
Empatica S.R.L.
Clinical Decision Support & Reference
Empatica Care is part of the Empatica Health Monitoring Platform, utilizing medical-grade wearables to collect continuous physiological data for remote patient monitoring and clinical research, accessible via a mobile app and web portal.

What the Web Says

Empatica S.R.L. develops medical-grade wearable devices and AI for remote health monitoring, particularly for epilepsy detection and physiological data collection. Their products, like the EmbracePlus and EpiMonitor, have received FDA clearance and are used in clinical research and at-home monitoring. While the technology is praised for its potential to save lives and provide valuable data, there are significant concerns regarding product functionality, customer service, and pricing models.

Overall: Mixed

Strengths

  • Effective seizure detection with high accuracy (98%) for tonic-clonic seizures, providing peace of mind for users and caregivers.
  • FDA-cleared for use in adults and children, making it a reliable medical wearable.
  • Collects comprehensive physiological data including pulse rate, respiratory rate, skin conductance, SpO2, and actigraphy.
  • Offers a patient-centered, intuitive design that aims to reduce barriers to study participation and increase patient compliance.
  • Company culture described as collaborative, challenging, and supportive, with opportunities for growth.
  • HRV measurements from Empatica E4 are considered valid for research and clinical contexts, especially under non-movement conditions.

Limitations

  • Frequent false alerts and missed actual seizures reported by some users.
  • Poor customer service with reports of unresponsiveness to critical device issues.
  • High cost of devices and a subscription-based model for essential features like caregiver notifications and seizure reports, which is seen as exploitative.
  • Issues with app connectivity, data uploading, and lack of real-time data access for some older models.
  • Limited accuracy for electrodermal activity and temperature measurements compared to established methods.
  • Battery life concerns and issues with the watch not working as advertised for some features like sleep and stress monitoring.

Based on reviews from: Facebook, Medigy, ResearchGate, Sleep Review, Indeed.com, Empatica.com, Reddit, Trustpilot, App Store

Last updated: 2026-10-17

Videos

News, demos, and interviews about Empatica S.R.L..

Loading videos...

Videos load interactively. If none appear, search YouTube for Empatica S.R.L. →

View all on YouTube

Press & Coverage

Medical Device Network
FDA clears Empatica's platform for Parkinson's monitoring
Empatica received FDA 510(k) clearance for its Health Monitoring Platform for Parkinson's, extending its clinical-grade remote monitoring technology into disease care. This follows the 2025 acquisition of PKG Health, integrating its Parkinson's symptom measures with Empatica's wearable devices.
2026-08
Empatica Blog
Empatica receives landmark FDA PCCP authorization for pulse oximetry
Empatica's Health Monitoring Platform received its sixth FDA clearance, this time for its pulse oximetry algorithm, with a Predetermined Change Control Plan (PCCP) allowing for algorithm updates without new 510(k) submissions.
2025-06
Empatica Blog
Empatica Acquires PKG Health to Transform Parkinson's Disease Monitoring
Empatica acquired PKG Health, a company specializing in movement disorder algorithms and digital endpoints for Parkinson's disease. This acquisition enhances Empatica's FDA-cleared wearable technology and health monitoring platform with validated algorithms for movement disorder monitoring.
2025-10
Empatica Blog
Empatica and McRoberts partnership achieves 200+ endpoints and opens platform to external algorithm developers
Empatica partnered with McRoberts to host all 71 of McRoberts' endpoints in Empatica's digital biomarkers portfolio and FDA-cleared platform, bringing the total offering to over 200. This collaboration enhances the Empatica Health Monitoring Platform with new measures in activity monitoring, energy expenditure, sleep movements, and functional mobility assessments.
2024-05
Empatica Blog
Empatica integrates Mobilise-D Mobility Outcomes into offering
Empatica partnered with Mobilise-D to integrate its validated Digital Mobility Outcomes (DMOs) into Empatica's Health Monitoring Platform. This collaboration provides 25 new, validated outcomes for conditions like COPD, Parkinson's, Multiple Sclerosis, and Proximal femoral fracture.
2024-06
Business Wire
Empatica Selected as a Technology Partner for Government Funded Decentralized Research Program
Empatica was selected as a technology partner for a government-funded decentralized research program, building on previous collaborations that led to advancements like an algorithm predicting respiratory infections.
2024-10
Empatica Blog
Empatica Receives New FDA Clearance for Cardiac Digital Biomarkers
Empatica's Health Monitoring Platform received another FDA clearance, expanding its capabilities to include cardiac digital biomarkers. Previous clearances in November 2022 included clinically validated digital biomarkers for Electrodermal Activity, SpO2, skin temperature, and movement during sleep.
2023-11
Empatica Blog
The Empatica Health Monitoring Platform receives FDA-clearance
The Empatica Health Monitoring Platform received its initial FDA clearance, enabling continuous collection of SpO2, EDA, skin temperature, and movement during sleep, opening new possibilities for novel therapeutics and digital biomarker development.
2022-11

Frequently Asked Questions

Empatica offers the Empatica Health Monitoring Platform, which includes medical-grade wearables like EmbracePlus and EmbraceMini, along with a cloud-based infrastructure and software. This platform enables continuous, remote monitoring of physiological parameters and digital biomarkers for various conditions, supporting both clinical trials and patient care.
Empatica has been a pioneer in digital biomarker development for over a decade, including the first FDA-cleared digital biomarker in neurology. Their platform provides a wide selection of clinically validated and research-grade digital biomarkers. They support monitoring for neurological conditions such as epilepsy (with EpiMonitor and Embrace2 for seizure detection) and Parkinson's disease, offering continuous tracking of motor symptoms and therapy response.
Empatica's products and platform are FDA-cleared and CE MDR certified, demonstrating their commitment to safety, effectiveness, and quality as medical devices. The Empatica Health Monitoring Platform has received multiple FDA clearances for continuous data collection, including SpO2, electrodermal activity, skin temperature, activity, pulse, and respiratory rate, as well as specific clearances for epilepsy and Parkinson's monitoring.
Empatica provides an end-to-end remote monitoring solution for clinical trials, including decentralized trials. Their platform allows for scalable data collection from thousands of devices, remote patient enrollment, wearable device provisioning and shipping, continuous automated data collection, and clinical data management. They also offer a Cloud API for seamless integration with existing Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC) platforms.
Empatica offers dedicated account management and support for clinical trials and research. They collaborate with research teams globally and their technology has been referenced in thousands of academic papers. Empatica also partners with organizations like the Digital Medicine Society (DiMe) to develop core digital measures.
Empatica designs and develops AI-enabled wearables, software, and digital biomarkers to advance health monitoring, forecasting, treatment, and research. Their wearables, such as EmbracePlus and EmbraceMini, utilize multiple sensors (PPG, EDA, accelerometer, gyroscope, magnetometer, temperature, ambient light) to collect continuous physiological data, which is then analyzed using machine learning algorithms.
Yes, Empatica's Health Monitoring Platform is applicable and scalable to numerous therapeutic areas. Beyond epilepsy and Parkinson's, their devices and platform support actigraphy for sleep and activity monitoring, providing insights into sleep patterns, circadian rhythms, and stress. They also contribute to research in areas like CNS, psychiatry, mental health, oncology, cardiovascular, and pain management.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.